Kamal Pandey

7PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 24, 2023
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy.

S M Nashir Udden, GuemHee Baek, Kamal Pandey

|Jan 11, 2022
Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase.

Kamal Pandey, Nar Bahadur Katuwal, Nahee Park

|Jan 30, 2021
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan, a Camptothecin Analogue, in Chemotherapy-Resistant Ovarian Cancer.

Jin Hur, Mithun Ghosh, Tae Heon Kim

|Jan 28, 2021
Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics.

Kamal Pandey, Eunbyeol Lee, Nahee Park

|Dec 02, 2020
Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence.

Kamal Pandey, Nahee Park, Kyung-Soon Park

|Nov 26, 2020
Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model.

Nahee Park, Kamal Pandey, Sei Kyung Chang

Pageof 2

Frequent Collaborators

5 joint publications

Yong Wha Moon

3 joint publications

Nahee Park

3 joint publications

Nar Bahadur Katuwal

1 joint publications

Hee-Jung An